InvestorsHub Logo

BiotechWill

07/18/13 11:20 AM

#10817 RE: 1millman #10812

Thank you kindly. It seemed that it was time someone ran a numbers scenario, even though I will be the first to admit there are several unknowns that make it difficult to get effectively beyond Q4 2013. We all know the science is there, so I think some modeling now and after Q2 earnings will be a great driver for both retail and institutional investing.